PlexBio Co., Ltd.
PlexBio Co., Ltd. develops and manufactures in vitro diagnostic reagents for molecular biology and immunology projects. It offers workflow navigation services; automated sample preparation kits; IntelliPlex platform that is designed for pCode technology with throughput sample-to-answer multiplexing assays; oncology assays, a portfolio for advanced molecular testing; and pCode coupling buffer sets… Read more
PlexBio Co., Ltd. - Asset Resilience Ratio
PlexBio Co., Ltd. (6572) has an Asset Resilience Ratio of 27.31% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2020–2024)
This chart shows how PlexBio Co., Ltd.'s Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down PlexBio Co., Ltd.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 0% |
| Short-term Investments | NT$143.20 Million | 27.31% |
| Total Liquid Assets | NT$143.20 Million | 27.31% |
Asset Resilience Insights
- Very High Liquidity: PlexBio Co., Ltd. maintains exceptional liquid asset reserves at 27.31% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
PlexBio Co., Ltd. Industry Peers by Asset Resilience Ratio
Compare PlexBio Co., Ltd.'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
FluroTech Ltd
OTCQB:FLURF |
Medical Devices | 0.00% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 0.50% |
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022 |
Medical Devices | 0.01% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.26% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 7.79% |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932 |
Medical Devices | 6.64% |
|
Shinhung
KO:004080 |
Medical Devices | 4.17% |
|
UMediC Group Berhad
KLSE:0256 |
Medical Devices | 1.48% |
Annual Asset Resilience Ratio for PlexBio Co., Ltd. (2020–2024)
The table below shows the annual Asset Resilience Ratio data for PlexBio Co., Ltd..
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 26.03% | NT$149.00 Million | NT$572.38 Million | -2.81pp |
| 2023-12-31 | 28.84% | NT$149.00 Million | NT$516.66 Million | -0.19pp |
| 2022-12-31 | 29.03% | NT$169.00 Million | NT$582.15 Million | -0.10pp |
| 2021-12-31 | 29.13% | NT$213.50 Million | NT$732.80 Million | -13.47pp |
| 2020-12-31 | 42.60% | NT$350.72 Million | NT$823.23 Million | -- |